Clinical Trial

Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.
Trial Details
NCT Number NCT07400224
Lead Sponsor Peking Union Medical College Hospital
Conditions Hyperthyroidism, Autoimmune, Cardiovascular Abnormalities, Malignant Tumor
Enrollment 600 participants
Start Date 2022-05-10
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10